| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |